Vemtoberant (APD418) mesylate is a β 3 -adrenergic receptor ( β 3 -AR ) antagonist with a human K i of 8.2 nM, and exhibits 400- to 600-fold selectivity over human β 1 -AR and β 2 -AR . Vemtoberant mesylate attenuates β 3 -AR-mediated cardiac inhibition. Vemtoberant mesylate can be used for the research of systolic heart failure.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Adrenergic Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.